187 related articles for article (PubMed ID: 15086722)
1. The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice.
Cui H; Chang XH; Liu B; Feng J; Li Y; Ye X; Cao SJ; Fu TY; Yao Y; Li HQ; Qian HN
Int J Gynecol Cancer; 2004; 14(2):234-41. PubMed ID: 15086722
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune responses induced by anti-idiotypic antibody fusion protein of 6B11scFv/hGM-CSF in BALB/c mice.
Chang XH; Ye X; Cui H; Feng J; Li Y; Zhu HL; Yang WL; Fu TY; Cheng HY; Guo HF
Chin Med J (Engl); 2006 Jan; 119(2):131-9. PubMed ID: 16454995
[TBL] [Abstract][Full Text] [Related]
3. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
[TBL] [Abstract][Full Text] [Related]
4. [The construction and expression of 6B11scFv anti-idiotypic antibody and human granulocyte-macrophage-colony stimulating factor in Escherichia coli].
Yang F; Qian H; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):417-9. PubMed ID: 11360654
[TBL] [Abstract][Full Text] [Related]
5. Construction, expression, and function of 6B11ScFv-mIL-12, a fusion protein that attacks human ovarian carcinoma.
Cheng H; Ye X; Chang X; Ma R; Cong X; Niu Y; Zhang M; Liu K; Cui H; Sang J
Med Oncol; 2015 Apr; 32(4):130. PubMed ID: 25794492
[TBL] [Abstract][Full Text] [Related]
6. [In vitro study of 6B11GM to induce cellular immunity in patients with ovarian carcinoma].
Yang F; Qian H; Feng J
Zhonghua Fu Chan Ke Za Zhi; 1999 Nov; 34(11):660-3. PubMed ID: 11479947
[TBL] [Abstract][Full Text] [Related]
7. [Immuno-therapeutic study of anti-idiotype minibody (single chain Fv-CH3) on ovarian carcinoma bearing mice].
Li Y; Chang XH; Cui H; Yang WL; Feng J; Wei LH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):451-6. PubMed ID: 12974094
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
9. [Study of immunization protocol of ovarian carcinoma associated 6B11 anti-idiotypical minibody].
Zhu HL; Li Y; Chang XH; Cui H; Feng J; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):52-6. PubMed ID: 16635330
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of a chimeric fusion protein consisting of an anti-idiotype antibody mimicking a breast cancer-associated antigen and the cytokine GM-CSF.
Tripathi PK; Qin H; Bhattacharya-Chatterjee M; Ceriani RL; Foon KA; Chatterjee SK
Hybridoma; 1999 Apr; 18(2):193-202. PubMed ID: 10380019
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
[TBL] [Abstract][Full Text] [Related]
12. [In vitro study of the antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY; Ye X; Zhu HL; Cheng HY; Cheng YX; Guo HF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):480-4. PubMed ID: 16224517
[TBL] [Abstract][Full Text] [Related]
13. Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity.
Dela Cruz JS; Trinh KR; Morrison SL; Penichet ML
J Immunol; 2000 Nov; 165(9):5112-21. PubMed ID: 11046042
[TBL] [Abstract][Full Text] [Related]
14. [The induction of specific immunity to human ovarian carcinoma cells by anti-idiotypic antibodies].
Lu WY; Qian HN; Li WJ
Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):27-9, 60-1. PubMed ID: 8033621
[TBL] [Abstract][Full Text] [Related]
15. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
Kwak LW; Young HA; Pennington RW; Weeks SD
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10972-7. PubMed ID: 8855293
[TBL] [Abstract][Full Text] [Related]
17. Single chain antibody vaccination in mice against human ovarian cancer enhanced by microspheres and cytokines.
Ma J; Li Z; Luo D
J Drug Target; 2003 Apr; 11(3):169-76. PubMed ID: 14577973
[TBL] [Abstract][Full Text] [Related]
18. [High-level expression of 6B11 ovarian carcinoma anti-idiotypic antibody scFv genes in E. Coli].
Liu Y; Qian H; Huang H
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):221-3. PubMed ID: 11601044
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
[TBL] [Abstract][Full Text] [Related]
20. [Specific immune cell therapy against ovarian cancer in vivo and in vitro].
Chang XH; Cheng HY; Cheng YX; Ye X; Guo HF; Fu TY; Zhang L; Zhang G; Cui H
Ai Zheng; 2008 Dec; 27(12):1244-50. PubMed ID: 19079987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
